Financial reports
20-F/A
2022 FY
Annual report (foreign) (amended)
13 Jun 23
20-F
2022 FY
Annual report (foreign)
26 Apr 23
20-F
2021 FY
Annual report (foreign)
20 May 22
NT 20-F
Notice of late annual filing (foreign)
29 Apr 22
20-F
2020 FY
Annual report (foreign)
17 May 21
NT 20-F
Notice of late annual filing (foreign)
30 Apr 21
20-F
2019 FY
Annual report (foreign)
17 Jun 20
NT 20-F
Notice of late annual filing (foreign)
15 Jun 20
20-F
2018 FY
Annual report (foreign)
4 Apr 19
Current reports
6-K
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
18 Apr 24
6-K
Report of Foreign Private Issuer
11 Apr 24
6-K
Tiziana Life Sciences Announces Podium Presentation at AD/PD of Nasal Anti-CD3 in Alzheimer’s Disease
5 Mar 24
6-K
Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients
8 Jan 24
6-K
Report of Foreign Private Issuer
5 Jan 24
6-K
Report of Foreign Private Issuer
5 Jan 24
6-K
Updated Interim Results for the Six Months Ended 30 June 2023
29 Dec 23
6-K
Report of Foreign Private Issuer
19 Dec 23
6-K
Report of Foreign Private Issuer
4 Dec 23
6-K
To Be Held As a “Remote Meeting” Only
1 Dec 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
1 Sep 23
F-3/A
Shelf registration (foreign) (amended)
25 Feb 22
F-3/A
Shelf registration (foreign) (amended)
1 Feb 22
8-K12B
Notification of registration of securities
21 Oct 21
25-NSE
Exchange delisting
20 Oct 21
F-3
Shelf registration (foreign)
26 Jan 21
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
27 Aug 20
F-6EF
Automatic registration for ADRs (foreign)
27 Aug 20
424B5
Prospectus supplement for primary offering
4 Aug 20
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
14 Jul 20
Proxies
No filings
Other
EFFECT
Notice of effectiveness
4 Mar 22
CORRESP
Correspondence with SEC
1 Mar 22
UPLOAD
Letter from SEC
1 Feb 21
EFFECT
Notice of effectiveness
7 Feb 20
CORRESP
Correspondence with SEC
4 Feb 20
UPLOAD
Letter from SEC
28 Jan 20
EFFECT
Notice of effectiveness
20 Nov 18
CORRESP
Correspondence with SEC
19 Nov 18
CORRESP
Correspondence with SEC
19 Nov 18
EFFECT
Notice of effectiveness
13 Nov 18